← Eichor
Study identifier: NCT05878912 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Effect of Obesity and Weight Loss in Heart Failure With Preserved Ejection Fraction

Condition: Heart Failure With Preserved Ejection Fraction · Obesity  ·  Sponsor: University of Oxford

PhaseNA
Planned participants120
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

This study looks at the effects of weight loss in people who have heart failure with preserved ejection fraction (HFpEF) and are overweight or obese. The main questions it aims to answer are whether weight loss in this group of people improves: 1. The heart's shape, how well it pumps blood and how well it uses fuels 2. The person's quality of life and how much they can exercise Participants will attend 2 study visits, separated by 3-6 months. The intervention period takes place in between the 2 study visits. Each study visit will involve measurements including: * Symptom and quality of life questionnaires * Body measurements such as height and weight * Blood tests * Ultrasound scans of the heart (echocardiogram) * Magnetic Resonance Imaging (MRI) scans of the heart * Exercise components during the scans * 6 minute walk test Participants are randomly allocated (in other words, by lottery) to either 'diet' or 'control' groups. The control group will continue standard care. The diet group will be enrolled in a weight loss program supervised by the study team. Participants in the diet group will replace their usual meals with meal replacement products specifically designed to deliver a low calorie diet for weight loss. The products will consist of formula soups, shakes and porridges. This diet would last 8 weeks, followed by a guided period of food reintroduction and maintenance.

This description comes directly from the study's public registry record.

Talk to the study team

Jiliu Pan, BMBCh  ·  +44(0)1865234591  ·  jiliu.pan@cardiov.ox.ac.uk

Jenny Rayner, DPhil  ·  +44(0)1865221172  ·  jenny.rayner@cardiov.ox.ac.uk

Always discuss trial participation with your own doctor first.

Locations (1)

Oxford Centre for Clinical Magnetic Resonance Research, John Radcliffe HospitalOxford, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05878912